(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LYNCBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LYNCBIO

ST13

US500000079419542

Class

42

Filing

79419542

Registration

8045439

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

08/19/2026

Trademark type

Word

Nice classes

42

Filing date

01/21/2025

Registration date

12/02/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/02/2025

Last transaction

08/19/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

CN

Examiner

SEVERSON, JUSTIN

Law office

M20

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

LYNCBIO THERAPEUTICS CO., LTD.

Representatives

Kathryn E. Smith WOOD HERRON & EVANS LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Technological research in the field of pharmaceuticals; research and development of new products for others; analysis of the mode of action of chemical combinations on animals; product quality testing; biochemical research and analysis; medical and scientific researchconducting clinical trials for others; development of pharmaceutical preparations and medicines; pharmaceutical research and development; scientific research for medical purposes in the area of cancerous diseases; biomedical research services; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

25 publications found

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/19/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

08/19/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/09/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/19/2026

FIMP

FINAL DISPOSITION PROCESSED

06/19/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/23/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/02/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/02/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/14/2025

PUBO

PUBLISHED FOR OPPOSITION

10/14/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/08/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/12/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/10/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/10/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/10/2025

RFNT

REFUSAL PROCESSED BY IB

08/29/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/13/2025

RFRR

REFUSAL PROCESSED BY MPU

08/13/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/01/2025

CNRT

NON-FINAL ACTION WRITTEN

06/30/2025

DOCK

ASSIGNED TO EXAMINER

06/30/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/21/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/21/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/20/2025

Continuous trademark protection

Get notified about every new filing that threatens LYNCBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.